Igor Chernukhin

Wivenhoe Park
Colchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial.

Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial.

Journal: Nature cancer
Published: February 11, 2025

Transcription factor switching drives subtype-specific pancreatic cancer.

Transcription factor switching drives subtype-specific pancreatic cancer.

Journal: Nature genetics
Published: February 17, 2024

ncRNAseq: simple modifications to RNA-seq library preparation allow recovery and analysis of mid-sized non-coding RNAs.

ncRNAseq: simple modifications to RNA-seq library preparation allow recovery and analysis of mid-sized non-coding RNAs.

Journal: BioTechniques
Published: November 29, 2021

Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer.

Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer.

Journal: Cancer research communications
Published: November 17, 2021

Elevated ASCL1 activity creates de novo regulatory elements associated with neuronal differentiation.

Elevated ASCL1 activity creates de novo regulatory elements associated with neuronal differentiation.

Journal: BMC genomics
Published: October 01, 2021

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer.

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer.

Journal: NPJ breast cancer
Published: March 15, 2021

Dephosphorylation of the Proneural Transcription Factor ASCL1 Re-Engages a Latent Post-Mitotic Differentiation Program in Neuroblastoma.

Dephosphorylation of the Proneural Transcription Factor ASCL1 Re-Engages a Latent Post-Mitotic Differentiation Program in Neuroblastoma.

Journal: Molecular cancer research : MCR
Published: August 11, 2020

TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions.

TET2 is a component of the estrogen receptor complex and controls 5mC to 5hmC conversion at estrogen receptor cis-regulatory regions.

Journal: Cell reports
Published: June 26, 2020

The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver.

The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver.

Journal: Oncogene
Published: March 24, 2020

Author Correction: ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response.

Author Correction: ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response.

Journal: Nature genetics
Published: February 02, 2020

The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen.

The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen.

Journal: Oncogene
Published: November 13, 2019

Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation.

Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation.

Journal: PloS one
Published: August 22, 2019
Showing 1-12 of 23

Last Updated: 09/26/2026